V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194371 | 20124572 | 1.9 | 64.4 | null | 2019-03-06 | 2019-03-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100592892 |
| 20194375 | 20124573 | 1.91 | 88 | Palliative (P) | 2020-11-11 | 2020-11-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100832912 |
| 20194377 | 20124574 | null | 35.8 | Palliative (P) | 2019-04-24 | 2019-05-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100571610 |
| 20194382 | 20124575 | 1.74 | 95 | null | 2017-02-26 | 2017-04-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100001965 |
| 20194384 | 20124576 | null | 80.7 | Palliative (P) | 2019-04-12 | 2019-04-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100825634 |
| 20194386 | 20124577 | 1.6 | 58 | Neo-adjuvant (N) | 2019-03-17 | 2019-04-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100389779 |
| 20194391 | 20124578 | 1.83 | 60.8 | null | 2020-09-01 | 2020-09-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100221252 |
| 20194398 | 20124579 | 1.69 | 49.9 | Palliative (P) | 2019-06-13 | 2019-06-24 | Docetaxel | 02 | N | DOCETAXEL | 101427560 |
| 20194401 | 20124580 | 1.72 | 86 | null | 2020-01-16 | 2020-01-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101701668 |
| 20194402 | 20124581 | 1.74 | 51.8 | null | 2019-09-22 | 2019-09-22 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100224652 |
| 20194403 | 20124582 | 1.6 | 82.8 | null | 2017-11-20 | 2017-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101654849 |
| 20194406 | 20124583 | 1.55 | null | Palliative (P) | 2017-07-06 | 2017-07-06 | Docetaxel | 02 | N | DOCETAXEL | 100057630 |
| 20194408 | 20124584 | 1.67 | null | Palliative (P) | 2016-05-18 | 2016-05-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101298193 |
| 20194412 | 20124585 | 1.7 | 54 | Adjuvant (A) | 2018-10-08 | 2018-10-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100317656 |
| 20194413 | 20124586 | 1.85 | 69.5 | Palliative (P) | 2017-03-08 | 2017-05-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100045655 |
| 20194414 | 20124587 | 1.67 | 59 | 02 | 2017-08-26 | 2017-09-15 | Docetaxel | 02 | N | DOCETAXEL | 100415990 |
| 20194426 | 20124588 | 1.9 | 104.1 | Palliative (P) | 2018-04-17 | 2018-04-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100671087 |
| 20194431 | 20124589 | 1.78 | 80 | null | 2017-01-20 | 2017-02-27 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101192436 |
| 20194432 | 20124590 | 1.5 | 61.9 | Palliative (P) | 2018-07-07 | 2018-07-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101408460 |
| 20194438 | 20124591 | 1.69 | 51.3 | Adjuvant (A) | 2019-12-21 | 2020-01-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100994626 |
| 20194446 | 20124592 | 1.74 | 53.1 | Palliative (P) | 2020-06-12 | 2020-07-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100131507 |
| 20194448 | 20124593 | 1.76 | 79 | Adjuvant (A) | 2018-09-22 | 2018-09-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101801220 |
| 20194453 | 20124594 | 1.76 | 88 | Palliative (P) | 2016-09-30 | 2016-10-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101357291 |
| 20194455 | 20124595 | 1.58 | 47.6 | Palliative (P) | 2019-02-08 | 2019-03-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100800877 |
| 20194463 | 20124596 | 1.73 | 91.15 | Palliative (P) | 2019-09-03 | 2019-09-03 | Docetaxel | 02 | N | DOCETAXEL | 101106752 |
| 20194468 | 20124597 | 1.63 | 79.7 | Palliative (P) | 2017-01-21 | 2017-01-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100361193 |
| 20194473 | 20124598 | 1.85 | 79 | Palliative (P) | 2016-10-18 | 2016-11-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101591577 |
| 20194475 | 20124599 | 1.85 | 79 | Palliative (P) | 2018-12-27 | 2019-01-12 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100544252 |
| 20194477 | 20124600 | 1.61 | 76 | Neo-adjuvant (N) | 2017-03-09 | 2017-03-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100943225 |
| 20194479 | 20124601 | 1.7 | 69.6 | Palliative (P) | 2017-01-04 | 2017-01-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101523547 |
| 20194492 | 20124602 | 2 | 70 | Palliative (P) | 2017-07-02 | 2017-08-03 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101698779 |
| 20194493 | 20124603 | 1.91 | 88.9 | null | 2020-02-10 | 2020-02-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100861534 |
| 20194498 | 20124604 | null | 86 | null | 2017-03-02 | 2017-03-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101600105 |
| 20194502 | 20124605 | 1.7 | 79.1 | null | 2016-11-25 | 2016-11-29 | Docetaxel | 02 | null | DOCETAXEL | 101529114 |
| 20194503 | 20124606 | 1.7 | 66.6 | Palliative (P) | 2021-11-21 | 2021-12-21 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101612119 |
| 20194504 | 20124607 | 1.63 | 62.6 | null | 2020-03-15 | 2020-04-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101378505 |
| 20194508 | 20124608 | 1.82 | 72 | Neo-adjuvant (N) | 2017-10-25 | 2017-10-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100125358 |
| 20194510 | 20124609 | 1.7 | 48.5 | Palliative (P) | 2019-07-26 | 2019-07-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101239912 |
| 20194513 | 20124610 | 1.61 | 54 | Palliative (P) | 2018-06-22 | 2018-07-15 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101193527 |
| 20194515 | 20124611 | 1.69 | 80 | Palliative (P) | 2016-06-13 | 2016-06-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101260317 |
| 20194520 | 20124612 | 1.67 | 68 | Palliative (P) | 2017-03-21 | 2017-03-27 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101061028 |
| 20194524 | 20124613 | 1.67 | 57.3 | Palliative (P) | 2017-08-09 | 2017-10-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101570906 |
| 20194527 | 20124614 | 1.84 | 99 | Palliative (P) | 2018-03-01 | 2018-03-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100989980 |
| 20194528 | 20124615 | 1.67 | 55.7 | Neo-adjuvant (N) | 2016-10-10 | 2016-11-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100825719 |
| 20194529 | 20124616 | 1.78 | 53 | null | 2018-03-10 | 2018-03-23 | Docetaxel 75mg/m2 (21 day) | 2 | null | DOCETAXEL | 101617465 |
| 20194532 | 20124617 | 1.72 | 77.2 | Palliative (P) | 2016-12-18 | 2016-12-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100590858 |
| 20194533 | 20124618 | 1.76 | 70 | null | 2020-12-21 | 2020-12-29 | Docetaxel | 02 | null | DOCETAXEL | 100062470 |
| 20194536 | 20124619 | 1.68 | 79.9 | Palliative (P) | 2019-08-09 | 2019-08-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101469529 |
| 20194538 | 20124620 | 1.84 | 86 | Palliative (P) | 2016-05-24 | 2016-05-26 | Docetaxel | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100679867 |
| 20194542 | 20124621 | 1.76 | 69.2 | null | 2020-10-06 | 2021-05-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100478716 |